<DOC>
	<DOCNO>NCT02808325</DOCNO>
	<brief_summary>It objective study investigate efficacy safety two different volume replacement regimens gelatine solution .</brief_summary>
	<brief_title>Study Efficacy Safety Gelaspan</brief_title>
	<detailed_description />
	<mesh_term>Hypovolemia</mesh_term>
	<mesh_term>Polygeline</mesh_term>
	<criteria>Inclusion : Male female patient ≥ 18 year age ≤ 80 year age . Patients schedule undergo open elective abdominal pelvic surgery . Anticipated intraoperative volume requirement gelatine solution least 15 mL/kg body weight Negative pregnancy test ( urine dipstick ) woman child bear potential . Provision voluntary consent participate study , follow full explanation nature purpose study , sign informed consent form approve regulatory authority Russian Federation Local Ethics Committee ( LEC ) prior evaluation . Exclusion : Patients ASAclass &gt; III . Known hypersensitivity gelatine constituent solution . Patients treat colloid solution / blood product 24 hour prior surgery . Patients hemodialysis . Patients suffer : Decompensated renal function ( i.e . serum creatinine &gt; 3.0 mg/dL ) Hypervolemia ; Severe heart failure ; Moderate lung edema ; Hyperhydration ; Severe blood coagulation disorder ( aPTT &gt; 2.5 x ULN fibrinogen &lt; 0.5 x LLN INR &gt; 2.5 x ULN ) ; Hypernatremia ( serum Na+ &gt; 150 mmol/L ) ; Hyperchloremia ( serum Cl &gt; 110 mmol/L ) ; Hypercalcemia ( serum ionize Ca++ &gt; 1.5 mmol/L ) ; Metabolic alkalosis ; Severe generalize edema ; Intracranial haemorrhage ; Hyperkalemia ( serum K+ &gt; 5.5 mmol/L ) . Pregnancy and/or nursing . Hypertension Systolic Blood Pressure &gt; 180 mm Hg Diastolic Blood Pressure &gt; 110 mm Hg identify screen . Patients investigator 's opinion could n't take part study . Simultaneous participation another clinical trial . Emergencies .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>